FDA Clearance Tracker · P140032-S058
Implantable System for Remodulin (ISR)
Last checked: Nov 20, 2026Latest source record: Jan 15, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Jan 15, 2021
Approved
Time to decision
179 days
Received Jul 20, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P140032-S058
- Device name
- Implantable System for Remodulin (ISR)
- Applicant
- Medtronic, Inc.
- Applicant location
- Minneapolis, MN
- Received
- Jul 20, 2020
- Decided
- Jan 15, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P140032
Device type
- Device class
- Class III
- Specialty
- Hospital Medicine & Nursing
FDA's approval statement
As written in FDA's record.
Approval of a material change from polyvinyl chloride (PVC) to Methyl Methacrylate Acrylonitrile Butadiene Styrene (MABS) on the extension set component of the Model 201106 Refill Kit for the Implantable System for Remodulin (ISR).
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.